Sánchez, V., Balko, J. M., Wescott, E., Sanders, M., Sun, X., Opalenik, S., . . . Pietenpol, J. (2023). 1002 Intratumor heterogeneity in MHC-I expression drives immunotherapy resistance and exposes NKG2A as a therapeutic target in breast cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationSánchez, Violeta, et al. 1002 Intratumor Heterogeneity in MHC-I Expression Drives Immunotherapy Resistance and Exposes NKG2A as a Therapeutic Target in Breast Cancer. BMJ Publishing Group, 2023.
MLA (9th ed.) CitationSánchez, Violeta, et al. 1002 Intratumor Heterogeneity in MHC-I Expression Drives Immunotherapy Resistance and Exposes NKG2A as a Therapeutic Target in Breast Cancer. BMJ Publishing Group, 2023.
Warning: These citations may not always be 100% accurate.